International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Metoprolol Tartrate 1.25-mg/mL Oral Liquid

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2011 - Volume 15, Number 5
View All Articles in Issue

Page(s): 421

Metoprolol Tartrate 1.25-mg/mL Oral Liquid Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Metoprolol Tartrate 1.25-mg/mL Oral Liquid. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen Jr., PhD, RPh, formulation, metoprolol tartrate, selective beta-1 blocker, hypertension, high blood pressure, angina, acute myocardial infarction, congestive heart failure

Related Categories: FORMULATIONS, CARDIOLOGY, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Metoprolol Tartrate 1.25-mg/mL Oral Liquid Allen Loyd V Jr	Sep/Oct 2011 Pg. 421
Metoprolol Tartrate 1-mg/mL Injection Allen Loyd V Jr	Jul/Aug 2013 Pg. 333
Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 503
Quantitation of Metoprolol Tartrate and Propranolol Hydrochloride in Pharmaceutical Dosage Forms: Stability of Metoprolol in an Aqueous Mixture Gupta Vishnu D, Maswoswe J	Mar/Apr 1997 Pg. 125-127
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Carvedilol 1.25-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2006 Pg. 220
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Metoprolol Tartrate 10-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 1997 Pg. 180
Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality Hagan John C III, Everett Eric, Chamberlain Tyler	May/Jun 2020 Pg. 194-197
Carvedilol 0.625-mg/mL Oral Liquid Allen Loyd V Jr	Sep/Oct 2011 Pg. 418
Stability of Alprazolam, Atropine Sulfate, Glutamine, Levofloxacin, Metoprolol Tartrate, Nitrofurantoin, Ondansetron Hydrochloride, Oxandrolone, Pregabaline, and Riboflavin in SyrSpend SF pH4 Oral Suspensions de Oliveira Ferreira Anderson, Polonini Hudson C, Loures da Silva Sharlene, Cerqueira de Melo Victor Augusto, de Andrade Laura, Fernandes Brandão Marcos Antônio	May/Jun 2017 Pg. 255-263
Congestive Heart Failure and Other Medical Facts About Ferrets; Scout's Story: A Case Report on Treating Congestive Heart Failure in a Ferret Williams LaVonn A, Riley Kari	Sep/Oct 2009 Pg. 367-371
Atenolol 1 mg/mL or 5 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	May/Jun 2018 Pg. 233
Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored Allen Loyd V Jr	Jul/Aug 2021 Pg. 327
Atenolol 25-, 50-, or 100-mg Capsules Allen Loyd V Jr	Jan/Feb 2015 Pg. 60
Coenzyme Q10 Supplementation in the Treatment of Heart Disease Bramwell Bethany L	Mar/Apr 2010 Pg. 108-111
Captopril 0.8 mg/mL in SyrSpend SF Oral Suspension Allen Loyd V Jr	Mar/Apr 2019 Pg. 148
Valsartan 4 mg/mL in Vehicle for Oral Solution USP Allen Loyd V Jr	Sep/Oct 2019 Pg. 412
Enalaprilat 1.25-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2012 Pg. 419
Return to Top